Alaunos Therapeutics Faces Delisting Concerns
Ticker: TCRT · Form: 8-K · Filed: Jul 2, 2025 · CIK: 1107421
| Field | Detail |
|---|---|
| Company | Alaunos Therapeutics, INC. (TCRT) |
| Form Type | 8-K |
| Filed Date | Jul 2, 2025 |
| Risk Level | high |
| Sentiment | bearish |
Sentiment: bearish
Topics: delisting, board-changes, officer-changes
TL;DR
Alaunos Therapeutics might get delisted, board shakeup happening.
AI Summary
Alaunos Therapeutics, Inc. filed an 8-K on July 2, 2025, reporting a notice of delisting or failure to satisfy a continued listing rule. The company also disclosed the departure of directors, election of new directors, appointment of officers, and compensatory arrangements. This filing indicates potential significant challenges for the company's continued listing on an exchange.
Why It Matters
This filing signals potential delisting, which could severely impact the company's stock liquidity and investor confidence.
Risk Assessment
Risk Level: high — The notice of delisting or failure to satisfy continued listing rules is a significant indicator of financial distress or non-compliance.
Key Players & Entities
- Alaunos Therapeutics, Inc. (company) — Registrant
- ZIOPHARM ONCOLOGY INC (company) — Former company name
- EASYWEB INC (company) — Former company name
FAQ
What is the primary reason for the notice of delisting or failure to satisfy a continued listing rule?
The filing does not explicitly state the primary reason for the notice of delisting or failure to satisfy a continued listing rule, but it is listed as a key item in the 8-K report.
When was the report filed?
The report was filed on July 2, 2025.
What other significant events are reported in this 8-K?
The filing also reports the departure of directors, election of directors, appointment of certain officers, and compensatory arrangements of certain officers.
What was Alaunos Therapeutics, Inc. formerly known as?
Alaunos Therapeutics, Inc. was formerly known as ZIOPHARM ONCOLOGY INC and EASYWEB INC.
Where is Alaunos Therapeutics, Inc. headquartered?
Alaunos Therapeutics, Inc. is headquartered at 2617 Bissonnet St, Suite 233, Houston, TX 77005.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on July 2, 2025 regarding Alaunos Therapeutics, Inc. (TCRT).